- Home
- NLSP vs IMCC Comparison
NLSP vs IMCC Comparison
Compare NLSP & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- IMCC
- Stock Information
- Founded
- NLSP 2015
- IMCC 1980
- Country
- NLSP Switzerland
- IMCC Israel
- Employees
- NLSP N/A
- IMCC N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- NLSP Health Care
- IMCC Health Care
- Exchange
- NLSP Nasdaq
- IMCC Nasdaq
- Market Cap
- NLSP 243.8M
- IMCC 5.0M
- IPO Year
- NLSP 2021
- IMCC N/A
- Fundamental
- Price
- NLSP $4.96
- IMCC $2.23
- Analyst Decision
- NLSP
- IMCC
- Analyst Count
- NLSP 0
- IMCC 0
- Target Price
- NLSP N/A
- IMCC N/A
- AVG Volume (30 Days)
- NLSP 34.6K
- IMCC 11.8K
- Earning Date
- NLSP 11-01-2024
- IMCC 11-11-2024
- Dividend Yield
- NLSP N/A
- IMCC N/A
- EPS Growth
- NLSP N/A
- IMCC N/A
- EPS
- NLSP N/A
- IMCC N/A
- Revenue
- NLSP N/A
- IMCC $36,445,402.00
- Revenue This Year
- NLSP N/A
- IMCC $22.59
- Revenue Next Year
- NLSP N/A
- IMCC $20.53
- P/E Ratio
- NLSP N/A
- IMCC N/A
- Revenue Growth
- NLSP N/A
- IMCC N/A
- 52 Week Low
- NLSP $4.08
- IMCC $1.13
- 52 Week High
- NLSP $29.68
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- NLSP 46.37
- IMCC 41.06
- Support Level
- NLSP $4.52
- IMCC $2.02
- Resistance Level
- NLSP $5.64
- IMCC $2.15
- Average True Range (ATR)
- NLSP 0.48
- IMCC 0.14
- MACD
- NLSP 0.07
- IMCC -0.01
- Stochastic Oscillator
- NLSP 55.44
- IMCC 19.15
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.